Literature DB >> 25935883

Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging.

Yoji Nagata1, Tetsuo Konno2, Noboru Fujino1, Akihiko Hodatsu1, Akihiro Nomura1, Kenshi Hayashi1, Hiroyuki Nakamura3, Masa-Aki Kawashiri1, Masakazu Yamagishi4.   

Abstract

BACKGROUND: Although left ventricular (LV) morphology and function have been well studied in hypertrophic cardiomyopathy (HCM), few data exist regarding the right ventricle. Accordingly, we studied right ventricular (RV) morphology and function and their effect on cardiovascular events in HCM using cardiac magnetic resonance (CMR) imaging.
METHODS: This retrospective study included 106 HCM patients (age 61.6 ± 14.5 years) examined using CMR imaging during January 2008 to September 2014. RV hypertrophy (RVH) was defined as RV maximal wall thickness > 5 mm.
RESULTS: RVH was observed in 30 of the 106 patients (RVH group), with the remaining 76 patients assigned to the non-RVH group. The RVH group had higher brain natriuretic peptide levels (461.6 ± 699.8 pg/mL vs. 225.3 ± 254.5 pg/mL; P = 0.01) and also showed a reduced RV end-diastolic volume index (43.4 ± 16.0 mL/m2 vs. 56.6±15.2 mL/m2; P = 0.0001), in keeping with a greater LV mass index (109.1 ± 24.9 g/m2 vs. 78.6 ± 23.0 g/m2; P < 0.0001). The RVH group was prominently associated with RV late gadolinium enhancement compared with the non-RVH group (33.3% vs. 0%; P < 0.0001). After CMR imaging, 15 patients developed cardiovascular events that included admission for heart failure, ventricular tachyarrhythmia/fibrillation, stroke, and sudden cardiac death. Cox proportional hazard analysis revealed that RVH was an independent predictor of the occurrence of cardiovascular events after adjustments by sex, age, LV mass index, LV ejection fraction, and LV outflow tract obstruction (hazard ratio, 5.42; 95% confidence interval, 1.16-25.3; P = 0.03).
CONCLUSIONS: These results suggest that HCM patients with RVH on CMR images have a greater incidence of cardiovascular events than non-RVH patients. Further work is needed to confirm this observation and assess its clinical importance.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25935883     DOI: 10.1016/j.cjca.2014.12.036

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  11 in total

1.  Right ventricle myectomy.

Authors:  Konstantin V Borisov
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  Severe right ventricular hypertrophy in hypertrophic cardiomyopathy: Serious symptoms, complex surgical procedures, and poor prognosis in Fuwai Hospital.

Authors:  Xueqi Dong; Di Zhang; Yi Qu; Xu Meng; Lin Zhao; Xianliang Zhou; Yaxin Liu
Journal:  Anatol J Cardiol       Date:  2021-07       Impact factor: 1.596

3.  Novel Echocardiographic Algorithm for Right Ventricular Mass Quantification: Cardiovascular Magnetic Resonance and Clinical Prognosis Validation.

Authors:  Jonathan Kochav; Jennifer Chen; Lakshmi Nambiar; Hannah W Mitlak; Arielle Kushman; Razia Sultana; Evelyn Horn; Arindam RoyChoudhury; Richard B Devereux; Jonathan W Weinsaft; Jiwon Kim
Journal:  J Am Soc Echocardiogr       Date:  2021-03-11       Impact factor: 7.722

4.  Trapped lung secondary to cardiomegaly in a 78 year-old male with congestive heart failure.

Authors:  Amy H Amabile; Susan D Moffatt-Bruce; Robert M DePhilip
Journal:  Respir Med Case Rep       Date:  2016-03-09

5.  Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy: A case report with RAF1 770C>T mutant.

Authors:  Xiaoqin Wang; Kaiyu Zhou; Yimin Hua; Yifei Li
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

6.  Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy.

Authors:  L C Visser; C Q Sloan; J A Stern
Journal:  J Vet Intern Med       Date:  2017-03-13       Impact factor: 3.333

7.  Prognostic significance of right ventricular hypertrophy and systolic function in Anderson-Fabry disease.

Authors:  Francesca Graziani; Rosa Lillo; Elena Panaioli; Maurizio Pieroni; Antonia Camporeale; Elena Verrecchia; Ludovico Luca Sicignano; Raffaele Manna; Antonella Lombardo; Gaetano Antonio Lanza; Filippo Crea
Journal:  ESC Heart Fail       Date:  2020-05-20

8.  Impaired Right Ventricular Mechanics at Rest and During Exercise Are Associated With Exercise Capacity in Patients With Hypertrophic Cardiomyopathy.

Authors:  Xiao-Peng Wu; Yi-Dan Li; Yi-Dan Wang; Miao Zhang; Wei-Wei Zhu; Qi-Zhe Cai; Wei Jiang; Lan-Lan Sun; Xue-Yan Ding; Xiao-Guang Ye; Yun-Yun Qin; Xiu-Zhang Lu
Journal:  J Am Heart Assoc       Date:  2019-03-05       Impact factor: 5.501

9.  Assessing right ventricular deformation in hypertrophic cardiomyopathy patients with preserved right ventricular ejection fraction: a 3.0-T cardiovascular magnetic resonance study.

Authors:  Xiang Li; Ke Shi; Zhi-Gang Yang; Ying-Kun Guo; Shan Huang; Chun-Chao Xia; Sen He; Zhen-Lin Li; Chen Li; Yong He
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

10.  Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy.

Authors:  Jiwon Seo; Yoo Jin Hong; Young Jin Kim; Purevjargal Lkhagvasuren; Iksung Cho; Chi Young Shim; Jong-Won Ha; Geu-Ru Hong
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.